No decision yet over e-cigs on health insurance…

Germany: The Federal Joint Committee responsible for defining what drugs statutorily insured people are entitled to has told ECigIntelligence that it has not yet decided whether e-cigarettes will be included as a smoking cessation drug. Discussions on the question were due to take place this year.
I'm already a subscriber

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization